Literature DB >> 19833150

Roles of perirhinal and posterior piriform cortices in control and generation of seizures: a microinfusion study in rats exposed to soman.

Trond Myhrer1, Siri Enger, Pål Aas.   

Abstract

Identification of critical receptors in seizure controlling brain regions may facilitate the development of more efficacious pharmacological therapies against nerve agent intoxication. In the present study, a number of drugs with anticonvulsant potency were microinfused into the perirhinal cortex (PRC) or posterior piriform cortex (PPC) in rats. The drugs used exert cholinergic antagonism (scopolamine), glutamatergic antagonism (ketamine, NBQX), both cholinergic and glutamatergic antagonism (procyclidine, caramiphen), or GABAergic agonism (muscimol). The results showed that in the PRC anticonvulsant efficacy against soman-induced seizures (subcutaneously administered) was achieved by procyclidine or NBQX, but not by ketamine, scopolamine, caramiphen, or muscimol (Experiment 1). Hence, both muscarinic and glutamatergic NMDA receptors had to be antagonized simultaneously or AMPA receptors alone, suggesting increased glutamatergic activation in the PRC before onset of seizures. In the PPC, anticonvulsant effects were assured by scopolamine or muscimol, but not by procyclidine, caramiphen, NBQX, or ketamine (Experiment 2). Thus, muscarinic and GABA(A) receptors appear to be the critical ones in the PPC. Microinfusion of soman into the PRC or PPC resulted in sustained seizure activity in the majority of the rats of both infusion categories. The rhinal structures encompassed in this study apparently have critical functions as both control and trigger sites for nerve agent-evoked seizures. 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19833150     DOI: 10.1016/j.neuro.2009.10.002

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  6 in total

1.  Susceptibility to Soman Toxicity and Efficacy of LY293558 Against Soman-Induced Seizures and Neuropathology in 10-Month-Old Male Rats.

Authors:  James P Apland; Vassiliki Aroniadou-Anderjaska; Taiza H Figueiredo; Eric M Prager; Cara H Olsen; Maria F M Braga
Journal:  Neurotox Res       Date:  2017-08-03       Impact factor: 3.911

2.  The M1 Muscarinic Receptor Antagonist VU0255035 Delays the Development of Status Epilepticus after Organophosphate Exposure and Prevents Hyperexcitability in the Basolateral Amygdala.

Authors:  Steven L Miller; Vassiliki Aroniadou-Anderjaska; Volodymyr I Pidoplichko; Taiza H Figueiredo; James P Apland; Jishnu K S Krishnan; Maria F M Braga
Journal:  J Pharmacol Exp Ther       Date:  2016-10-31       Impact factor: 4.030

3.  Neuroprotection From Organophosphate-Induced Damage by Novel Phenoxyalkyl Pyridinium Oximes in Rat Brain.

Authors:  Ronald B Pringle; Edward C Meek; Howard W Chambers; Janice E Chambers
Journal:  Toxicol Sci       Date:  2018-12-01       Impact factor: 4.849

4.  A rodent model of human organophosphate exposure producing status epilepticus and neuropathology.

Authors:  W Pouliot; S L Bealer; B Roach; F E Dudek
Journal:  Neurotoxicology       Date:  2016-08-12       Impact factor: 4.294

Review 5.  The piriform, perirhinal, and entorhinal cortex in seizure generation.

Authors:  Marta S Vismer; Patrick A Forcelli; Mark D Skopin; Karen Gale; Mohamad Z Koubeissi
Journal:  Front Neural Circuits       Date:  2015-05-29       Impact factor: 3.492

6.  Characterizing functional pathways of the human olfactory system.

Authors:  Guangyu Zhou; Gregory Lane; Shiloh L Cooper; Thorsten Kahnt; Christina Zelano
Journal:  Elife       Date:  2019-07-24       Impact factor: 8.140

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.